DK412489D0 - Alfa-underenheden af mac-1-leukocytadhaesionsreceptoren - Google Patents

Alfa-underenheden af mac-1-leukocytadhaesionsreceptoren

Info

Publication number
DK412489D0
DK412489D0 DK412489A DK412489A DK412489D0 DK 412489 D0 DK412489 D0 DK 412489D0 DK 412489 A DK412489 A DK 412489A DK 412489 A DK412489 A DK 412489A DK 412489 D0 DK412489 D0 DK 412489D0
Authority
DK
Denmark
Prior art keywords
leukocytadhaesion
alfa
mac
receptor
substances
Prior art date
Application number
DK412489A
Other languages
English (en)
Other versions
DK412489A (da
Inventor
Timothy Alan Springer
Angel Corbi
Original Assignee
Dana Farber Cancer Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dana Farber Cancer Inst Inc filed Critical Dana Farber Cancer Inst Inc
Publication of DK412489D0 publication Critical patent/DK412489D0/da
Publication of DK412489A publication Critical patent/DK412489A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2845—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70525—ICAM molecules, e.g. CD50, CD54, CD102
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • C07K14/70553—Integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK412489A 1988-08-23 1989-08-22 Alfa-underenheden af mac-1-leukocytadhaesionsreceptoren DK412489A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23535388A 1988-08-23 1988-08-23
US32123989A 1989-03-09 1989-03-09

Publications (2)

Publication Number Publication Date
DK412489D0 true DK412489D0 (da) 1989-08-22
DK412489A DK412489A (da) 1990-02-24

Family

ID=26928829

Family Applications (1)

Application Number Title Priority Date Filing Date
DK412489A DK412489A (da) 1988-08-23 1989-08-22 Alfa-underenheden af mac-1-leukocytadhaesionsreceptoren

Country Status (13)

Country Link
US (3) US5849896A (da)
EP (1) EP0364690A3 (da)
JP (1) JPH0347077A (da)
KR (1) KR0185964B1 (da)
AU (1) AU638937B2 (da)
CA (1) CA1341293C (da)
DK (1) DK412489A (da)
FI (1) FI893917L (da)
HU (1) HU213014B (da)
IL (1) IL91370A (da)
NO (1) NO893367L (da)
NZ (1) NZ230397A (da)
PT (1) PT91502B (da)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01502879A (ja) * 1987-02-26 1989-10-05 ダナ　ファーバー　キャンサー　インスティテュート Ｌｆａ―１のクローニング
US5395929A (en) * 1987-12-15 1995-03-07 Dana Farber Cancer Institute Isolated nucleic acid encoding the alpha subunit of the human leukocyte adhesion receptor
US5877275A (en) * 1988-06-28 1999-03-02 The General Hospital Corporation Controlling cellular immune/inflammatory responses with β2 integrins
EP0364690A3 (en) 1988-08-23 1990-07-18 Dana Farber Cancer Institute The alpha-subunit of the mac-1 leukocyte adhesion receptor
US6051231A (en) * 1988-09-01 2000-04-18 Bayer Corporation Antiviral methods and prepations
US6143298A (en) * 1988-09-01 2000-11-07 Bayer Corporation Soluble truncated forms of ICAM-1
ZA896668B (en) * 1988-09-01 1990-06-27 Molecular Therapeutics Inc A human rhinovirus receptor protein that inhibits virus infectivity
US6514936B1 (en) 1988-09-01 2003-02-04 Bayer Corporation Antiviral methods using human rhinovirus receptor (ICAM-1)
JPH04505613A (ja) * 1989-03-09 1992-10-01 ダナ・ファーバー・キャンサー・インスティチュート 白血球付着レセプター
EP0462184A4 (en) * 1989-03-09 1992-01-08 Dana Farber Cancer Institute Method of treating viral infections using lfa-1
US5686582A (en) * 1990-07-20 1997-11-11 Bayer Corporation Multimeric forms of human rhinovirus receptor protein
EP0468257B1 (en) * 1990-07-20 1999-09-01 Bayer Corporation Multimeric form of human rhinovirus receptor protein
US6107461A (en) * 1990-07-20 2000-08-22 Bayer Corporation Multimeric forms of human rhinovirus receptor and fragments thereof, and method of use
US5674982A (en) * 1990-07-20 1997-10-07 Bayer Corporation Multimeric form of human rhinovirus receptor protein
JPH08502956A (ja) * 1992-10-09 1996-04-02 センター、フォー、ブラッド、リサーチ、インコーポレーテッド ＩＣＡＭ‐１及びフィブリノーゲンへの好中球接着を媒介するＭａｃ‐１（ＣＤ１１ｂ／ＣＤ１８）分子のサブ集団
EP0758393A1 (en) * 1994-04-26 1997-02-19 PHARMACIA & UPJOHN COMPANY Mac-1 i-domain protein useful in blocking adhesion and migration of neutrophils
EP0769958B1 (en) * 1994-07-11 2003-04-16 Athena Neurosciences, Inc. Inhibitors of leukocyte adhesion
US5696229A (en) * 1995-03-16 1997-12-09 The University Of Virginia Patent Foundation Polypeptide with laminin cell adhesion and morphogenesis activity
US6037454A (en) 1996-11-27 2000-03-14 Genentech, Inc. Humanized anti-CD11a antibodies
US7400477B2 (en) 1998-08-24 2008-07-15 Leviton Manufacturing Co., Inc. Method of distribution of a circuit interrupting device with reset lockout and reverse wiring protection
US6210897B1 (en) 1999-05-26 2001-04-03 Leif Andersson Identification of canine leukocyte adhesion deficiency in dogs
AU4574501A (en) 2000-03-17 2001-10-03 Millennium Pharm Inc Method of inhibiting stenosis and restenosis
ATE448306T1 (de) 2000-09-01 2009-11-15 Blood Res Center Veränderte, in gewünschter konformation stabilisierte polypeptide und verfahren zu deren herstellung
US7852606B2 (en) * 2005-08-24 2010-12-14 Leviton Manufacturing Company, Inc. Self-testing circuit interrupting device
US7372678B2 (en) * 2005-08-24 2008-05-13 Leviton Manufacturing Co., Inc. Circuit interrupting device with automatic test
US7911746B2 (en) * 2006-06-01 2011-03-22 Leviton Manufacturing Co., Inc. GFCI with self-test and remote annunciation capabilities
US8603628B2 (en) * 2007-04-30 2013-12-10 Saint-Gobain Performance Plastics Corporation Turbine blade protective barrier
CA2711903C (en) 2008-01-29 2019-01-15 Leviton Manufacturing Co., Inc. Self testing fault circuit interrupter apparatus and method
US9759758B2 (en) 2014-04-25 2017-09-12 Leviton Manufacturing Co., Inc. Ground fault detector

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4761371A (en) * 1985-02-12 1988-08-02 Genentech, Inc. Insulin receptor
US5424399A (en) * 1988-06-28 1995-06-13 The Children's Medical Center Corporation Human CR3α/β heterodimers
EP0364690A3 (en) 1988-08-23 1990-07-18 Dana Farber Cancer Institute The alpha-subunit of the mac-1 leukocyte adhesion receptor

Also Published As

Publication number Publication date
US6683158B2 (en) 2004-01-27
EP0364690A3 (en) 1990-07-18
JPH0347077A (ja) 1991-02-28
NZ230397A (en) 1997-07-27
NO893367D0 (no) 1989-08-22
US20020022595A1 (en) 2002-02-21
FI893917A7 (fi) 1990-02-24
AU4014489A (en) 1990-03-01
FI893917A0 (fi) 1989-08-21
HUT54207A (en) 1991-01-28
PT91502A (pt) 1990-03-08
IL91370A (en) 1995-07-31
FI893917L (fi) 1990-02-24
US5849896A (en) 1998-12-15
DK412489A (da) 1990-02-24
KR900002797A (ko) 1990-03-23
EP0364690A2 (en) 1990-04-25
US20030013850A1 (en) 2003-01-16
KR0185964B1 (ko) 1999-05-01
HU213014B (en) 1997-01-28
AU638937B2 (en) 1993-07-15
CA1341293C (en) 2001-09-18
IL91370A0 (en) 1990-04-29
NO893367L (no) 1990-02-26
PT91502B (pt) 1995-05-04

Similar Documents

Publication Publication Date Title
DK412489D0 (da) Alfa-underenheden af mac-1-leukocytadhaesionsreceptoren
FI874804A7 (fi) Bisykliset yhdisteet.
DK272589D0 (da) Blandingsapparat
NO895010D0 (no) Konstruksjonsmateriale.
BR8704567A (pt) Composicao de resina termofixavel
DK295889D0 (da) Fremgangsmaade til sammenklaebning af materialelag
FI912378A0 (fi) Sekoituslaite
DE68909432D1 (de) Direkte fixierung von geflochtenen strukturen.
DE68927655D1 (de) Analog-Digital-Wandler
TR24653A (tr) Aciloksinitrojen perasit iptidai maddeler
BR8703792A (pt) Composicao de resina
DK601489A (da) Fremgangsmaade til fremstilling af alkansulfonamider
BR8703314A (pt) Material de friccao
FR2596792B1 (fr) Element de construction autoverrouillable
BR8706749A (pt) Conjunto de construcao
FI892469L (fi) Sekaraaka-aineista valmistettuja absorboivia rakenteita
DK541487D0 (da) Sammenfoejning af materialer
DK318689A (da) Anvendelse af lactamimider til fremstilling af calcium-antagonister
KR900008475U (ko) 진개 제거기
KR900000655U (ko) 물통의 뚜껑
DK621088D0 (da) Theemballage af theposetypen
DK162789D0 (da) Fremgangsmaade til fremstilling af alkalimetalphenylpyruvat
FR2637306B1 (fr) Element de construction
DK164273C (da) Affaldsbeholder
BR6900024U (pt) Disposicao introduzida no nivel de pedreiro-ii

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment